rosuvastatin
NDA- Indications
- Hypercholesterolemia
Company intelligence / Profile preview
Idea Evolver has successfully supported Actual Use Trials for FDA review in the context of prescription-to-over-the-counter drug switches. Their proprietary CodeScripts platform has been used to facilitate applications such as the OTC switch for STENDRA® (avanafil) and Crestor® (rosuvastatin). They are recognized as the only provider with documented experience advancing a currently available drug through an Actual Use Trial toward potential OTC approval.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Idea Evolver.